Vaccine News and Research

Latest Vaccine News and Research

Locals resist efforts to control the worst ever outbreak of Marburg

The World Health Organisation (WHO) have sent communications experts into Uige, the epicentre of the outbreak of Marburg epidemic to help Health experts in the fight to contain and eradicate the killer virus. It is hoped they will send a clear message to Angolans to take the necessary measures to fight the virus.

12 Apr 2005

Now revealed that Salk polio vaccine was a team effort

The cure for polio came as a result of the collaboration between Thomas Francis Jr. and Jonas Salk.

10 Apr 2005

UAB reaction to Lancet study on human papilloma virus (HPV)

The prominent British medical journal Lancet published results of a clinical trial on a vaccine for human papilloma virus (HPV) The virus is a leading cause of cervical cancer and genital warts.

10 Apr 2005

Attacks on WHO staff - progress on Marburg epidemic halted

The World Health Organization (WHO) has suspended its efforts to contain the outbreak of the deadly Marburg virus in Angola, in the northern province of Uige, after staff in their mobile surveillance vehicles have been attacked.

10 Apr 2005

Race to market cancer vaccine

In a race to market the first vaccine against the virus that causes cervical cancer and genital warts drug manufacturers Merck & Co Inc. and GlaxoSmithKline plc are in head-to-head competition.

7 Apr 2005

Vaccine against cervical cancer and genital warts looks hopeful

More than two thirds of sexually active women will become infected with human papillomavirus (HPV) during their lifetime. HPV causes around 470 000 cases of cervical cancer each year and even though most cases of cervical cancer occur in the developing world, where cervical screening programmes are in the main non-existent, in Europe and the US 35000 women die from the disease every year.

6 Apr 2005

Stress might actually be beneficial to health

New research has surprisingly shown that stress, generally thought to be bad for the immune system by lowering the body's ability to fight off disease, on a short-term basis might actually be beneficial.

6 Apr 2005

SV40 does not have a role in the majority of malignant mesotheliomas

SV40 does not have a role in the majority of malignant mesotheliomas -- a cancer associated with exposure to asbestos – according to a study in this month's Cancer Research. The study, led by Mount Sinai School of Medicine researchers used a scrupulous protocol that eliminated contamination that has likely been the reason previous studies have implicated SV40 in this cancer.

6 Apr 2005

Hormonal contraceptives increase risk of HSV-2 transmission

Women who are infected with herpes simplex virus type 2 (HSV-2) may have an increased risk of transmitting the virus to others if they use hormonal contraceptives or have certain bacterial vaginal infections, according to an article in the May 15 issue of Clinical Infectious Diseases, now available online.

6 Apr 2005

Pneumonia jab now available for over 65s in UK

People over 65 in the UK are to be offered a routine jab to help protect against diseases, including pneumonia, meningitis and septicaemia. Two in 1,000 over-65s are admitted to hospital with pneumococcal pneumonia each year and the infection can cause serious diseases.

5 Apr 2005

Important trial in the fight against lung cancer

Two University of Kentucky researchers continue their work with a vaccine to prevent lung cancer recurrences in patients following primary treatment of the disease.

5 Apr 2005

When treating malaria is a waste of money

Africa may fail to benefit from new and better drugs for malaria because of massive misdiagnosis of the disease by health workers and patients.

5 Apr 2005

International commitment to reduce maternal and child deaths by 2015 will not be met

An international commitment to reduce maternal and child deaths by 2015 will not be met at the current pace unless rapid and coordinated action is taken now, the World Health Organization (WHO) has warned.

5 Apr 2005

Much more money needed to tackle flu virus

The World Health Organisation (WHO) is recommending that governments throughout the world need to set aside 5 per cent of what they spend on influenza vaccines to help get ready for the next big flu epidemic.

4 Apr 2005

Immune cells in the liver travel in the liver's blood vessels with surprising speed and agility

Scientists at New York University School of Medicine viewing the actual journey of immune cells in the liver have found that these cells travel in the liver's blood vessels with surprising speed and agility.

4 Apr 2005

Rabies, HIV, cancer and malaria could all be prevented with pills in the future

Rabies, HIV, cancer and malaria could all be prevented with pills in the future, if a new technique using specially modified viruses to deliver vaccines is adopted, according to scientists speaking today (Tuesday, 05 April 2005) at the Society for General Microbiology's 156th Meeting at Heriot-Watt University, Edinburgh.

4 Apr 2005

Unravelling the Ebola virus’s biological cycle

Ebola virus infection in humans provokes a violent haemorrhagic fever. It usually flares up as intense epidemics. These kill 80 % of the people infected. Seven such outbreaks have hit Gabon and the Republic of Congo since 1994, leading to 445 cases resulting in 361 deaths.

4 Apr 2005

$2.6 million complaint filed against Illinois by British Ecosse Hospital Products

Gov. Rod Blagojevich of Illinois has had a legal complaint demanding nearly $2.6 million filed against him by a British wholesaler Ecosse Hospital Products Ltd. for 254,250 doses of a flu vaccine ordered by Blagojevich to provide thousands of flu vaccine doses for Illinois.

4 Apr 2005

HHS awards $97 million contract to Sanofi Pasteur to speed the production process for new influenza vaccines

United States Department of Health and Human Services has awarded a $97 million contract to Sanofi Pasteur to speed the production process for new influenza vaccines for the U.S.

3 Apr 2005

Novel strategy to create a genetic vaccine against P. aeruginosa

Pseudomonas aeruginosa is a bacterium that can cause respiratory tract infections, which can be life threatening in patients who have cystic fibrosis. It is therefore important to develop a vaccine against this pathogen.

3 Apr 2005